Barclays initiates Humacyte at equal-weight
Barclays initiated coverage of Humacyte with an equal-weight rating, according to Benzinga's ratings update.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Barclays initiates Humacyte coverage at Equal Weight, $0.5 target
Barclays started coverage of Humacyte (HUMA) with an Equal Weight rating and a $0.5 price target.